The emerging therapy of the medication represents a exciting development in the management of type 2 diabetes. Unlike existing therapies, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatide-peptide745926.getblogs.net/74654813/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment